Sitemap > Breaking Research > Cancer Immunotherapy
Displaying 651 - 700 of 1868 results
- A Phase I Pilot Study of Autologous Heat Shock Protein Vaccine HSPPC-96 in Patients With Resected Pancreatic Adenocarcinoma.
- Flt3-L gene therapy enhances immunocytokine-mediated antitumor effects and induces long-term memory.
- Antitumor effects of vaccination with dendritic cells transfected with modified receptor for hyaluronan-mediated motility mRNA in a mouse glioma model.
- Co-application of ricin A chain and a recombinant adenovirus expressing ricin B chain as a novel approach for cancer therapy.
- Cytotoxic T lymphocyte response induced by an improved synthetic lipopeptide vaccine against cervical cancer.
- Targeting CD37+ lymphoid malignancies with a novel engineered small modular immunopharmaceutical.
- CD200 expression on tumor cells suppresses antitumor immunity: new approaches to cancer immunotherapy.
- Evaluation of cancer virotherapy with attenuated replicative Semliki forest virus in different rodent tumor models.
- An agonist antibody specific for CD40 induces dendritic cell maturation and promotes autologous anti-tumour T-cell responses in an in vitro mixed autologous tumour cell/lymph node cell model.
- Results of a pilot trial of immunotherapy with dendritic cells pulsed with autologous tumor lysates in patients with advanced cancer.
- Induction of adaptive Anti-HER2/neu immune responses in a Phase 1B/2 trial of 2B1 bispecific murine monoclonal antibody in metastatic breast cancer (E3194): a trial coordinated by the Eastern Cooperative Oncology Group.
- Salmonella typhimurium stimulation combined with tumour-derived heat shock proteins induces potent dendritic cell anti-tumour responses in a murine model.
- Targeted and untargeted CD137L fusion proteins for the immunotherapy of experimental solid tumors.
- Chemical glycosylation in the synthesis of glycoconjugate antitumour vaccines.
- A novel pretargeting method for measuring antibody internalization in tumor cells.
- An antibody directed against PDGF receptor beta enhances the antitumor and the anti-angiogenic activities of an anti-VEGF receptor 2 antibody.
- Locoregional IL-2 therapy in the treatment of colon cancer. Cell-induced lesions of a murine model.
- Neutropenic events in community practices reduced by first and subsequent cycle pegfilgrastim use.
- Dendritic cell-based full-length survivin vaccine in treatment of experimental tumors.
- In vitro antitumoral activity of baculovirus-expressed chimeric recombinant anti-CD4 antibody 13B8.2 on T-cell lymphomas.
- Phase I trial of vaccination with autologous neuroblastoma tumor cells genetically modified to secrete IL-2 and lymphotactin.
- Phase II study of FOLFOX, bevacizumab and erlotinib as first-line therapy for patients with metastastic colorectal cancer.
- Inhibition of angiogenesis and tumor metastasis by targeting a matrix immobilized cryptic extracellular matrix epitope in laminin.
- Relaxin-expressing, fiber chimeric oncolytic adenovirus prolongs survival of tumor-bearing mice.
- Interferon gamma Stimulates Cellular Maturation of Dendritic Cell Line DC2.4 Leading to Induction of Efficient Cytotoxic T Cell Responses and Antitumor Immunity.
- A multicentre phase II study of carboplatin plus pegylated liposomal doxorubicin as first-line chemotherapy for patients with advanced or recurrent endometrial carcinoma: the END-1 study of the MITO (Multicentre Italian Trials in Ovarian Cancer and Gynecologic Malignancies) group.
- Flt3 ligand promotes myeloid dendritic cell differentiation of human hematopoietic progenitor cells: Possible application for cancer immunotherapy.
- Long-circulating poly(ethylene glycol)-coated emulsions to target solid tumors.
- A CD19-specific single-chain immunotoxin mediates potent apoptosis of B-lineage leukemic cells.
- Oral delivery of tumor-targeting Salmonella for cancer therapy in murine tumor models.
- Phase I study with an autologous tumor cell vaccine for locally advanced or metastatic prostate cancer.
- Poly(D,L-Lactic-Co-Glycolic Acid) microsphere delivery of adenovirus for vaccination.
- Evaluation of anti-tumor effects of tumor cell lysate enriched by HSP-70 against fibrosarcoma tumor in BALB/c mice.
- Radiolabeled high affinity peptidomimetic antagonist selectively targets alpha(v)beta(3) receptor-positive tumor in mice.
- Novel role of triazenes in haematological malignancies: Pilot study of Temozolomide, Lomeguatrib and IL-2 in the chemo-immunotherapy of acute leukaemia.
- Intratumoral delivery of vector mediated IL-2 in combination with vaccine results in enhanced T cell avidity and anti-tumor activity.
- Meta analysis of advanced cancer survival data using lognormal parametric fitting: a statistical method to identify effective treatment protocols.
- Immunization of High-Risk Breast Cancer Patients with Clustered sTn-KLH Conjugate plus the Immunologic Adjuvant QS-21.
- E1A, E1B Double-Restricted Adenovirus with RGD-Fiber Modification Exhibits Enhanced Oncolysis for CAR-Deficient Biliary Cancers.
- Increasing Anticarcinoma Activity of an Anti-erbB2 Recombinant Immunotoxin by the Addition of an Anti-EpCAM sFv.
- Melanoma-infiltrating dendritic cells induce protective antitumor responses mediated by T cells.
- Endostatin plus interferon-alpha2b therapy for metastatic melanoma: a novel combination of antiangiogenic and immunomodulatory agents.
- Increased Sensitivity of Radiated Murine Cervical Cancer Tumors to E7 Subunit Vaccine-driven CTL-mediated Killing Induces Synergistic Anti-tumor Activity.
- Effects of G207, a conditionally replication-competent oncolytic herpes simplex virus, on the developing mammalian brain.
- Targeting of humanized antibody D93 to sites of angiogenesis and tumor growth by binding to multiple epitopes on denatured collagens.
- CTLA-4 blockade in murine bone marrow chimeras induces a host-derived antileukemic effect without graft-versus-host disease.
- Antitumor effects of imidazoquinolines in urothelial cell carcinoma of the bladder.
- Expansion of CD4(+)CD25(+) suppressive regulatory T cells from rhesus macaque peripheral blood by FN18/antihuman CD28-coated Dynal beads.
- Phase I and Pharmacokinetic Study of Vorinostat, A Histone Deacetylase Inhibitor, in Combination with Carboplatin and Paclitaxel for Advanced Solid Malignancies.
- Scavenger receptor-a-targeted leukocyte depletion inhibits peritoneal ovarian tumor progression.